Relationship between albumin-globulin ratio and prostate-specific antigen: a cross-sectional study based on NHANES 2003–2010
Purpose The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported. Methods This cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and...
Saved in:
Published in | BMC urology Vol. 25; no. 1; pp. 3 - 8 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
07.01.2025
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1471-2490 1471-2490 |
DOI | 10.1186/s12894-024-01687-2 |
Cover
Abstract | Purpose
The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported.
Methods
This cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests.
Results
This study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an “L”-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA.
Conclusion
In the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32.
Clinical trial number
Not applicable. |
---|---|
AbstractList | Purpose The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported. Methods This cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests. Results This study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an "L"-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA. Conclusion In the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32. Clinical trial number Not applicable. Keywords: Albumin-globulin ratio, Prostate-specific antigen, NHANES, Cross-sectional study The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported. This cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests. This study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an "L"-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA. In the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32. Not applicable. The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported. This cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests. This study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an "L"-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA. In the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32. Purpose The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported. Methods This cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests. Results This study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an “L”-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA. Conclusion In the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32. Clinical trial number Not applicable. PurposeThe albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported.MethodsThis cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests.ResultsThis study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an “L”-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA.ConclusionIn the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32.Clinical trial numberNot applicable. The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported.PURPOSEThe albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported.This cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests.METHODSThis cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests.This study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an "L"-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA.RESULTSThis study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an "L"-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA.In the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32.CONCLUSIONIn the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32.Not applicable.CLINICAL TRIAL NUMBERNot applicable. Abstract Purpose The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported. Methods This cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests. Results This study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an “L”-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA. Conclusion In the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32. Clinical trial number Not applicable. |
ArticleNumber | 3 |
Audience | Academic |
Author | Ding, Sijuan Gao, Simeng Wu, Baofang Tang, Zhaohui Wang, Jiayin Li, Shaojie |
Author_xml | – sequence: 1 givenname: Simeng surname: Gao fullname: Gao, Simeng organization: The Central Hospital of Yongzhou – sequence: 2 givenname: Shaojie surname: Li fullname: Li, Shaojie organization: The Second Affiliated Hospital of Fujian Medical University – sequence: 3 givenname: Baofang surname: Wu fullname: Wu, Baofang organization: The Second Affiliated Hospital of Fujian Medical University – sequence: 4 givenname: Jiayin surname: Wang fullname: Wang, Jiayin organization: The Second Affiliated Hospital of Fujian Medical University – sequence: 5 givenname: Sijuan surname: Ding fullname: Ding, Sijuan organization: The Central Hospital of Yongzhou – sequence: 6 givenname: Zhaohui surname: Tang fullname: Tang, Zhaohui email: tangzhaohui2023@163.com organization: The Central Hospital of Yongzhou |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39762822$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kstu1DAUhiNURC_wAiyQJTZsUnyJHYcNGlWFVqqKxGVt2c5J6lHGHuykqBvEO_CGPAnOTGk7CCHLsnX8nd_n2P9hseeDh6J4TvAxIVK8ToTKpioxzZMIWZf0UXFAqpqUtGrw3oP9fnGY0hJjUksunhT7rKkFlZQeFN8_wqBHF3y6cmtkYPwG4JEezLRyvuyHYKbBeRRnBmnfonUMadQjlGkN1nXO5ujoevBvkEY2H6YygZ0V9YDSOLU3yOgELQoeXZ4tLk8_IYox-_XjJ8UEPy0ed3pI8Ox2PSq-vDv9fHJWXnx4f36yuCgt581Y1o1mraCE2Y40lNQNxZVp21o00gguwdoK2w5TsK3lotPACeGECks45S3n7Kg43-q2QS_VOrqVjjcqaKc2gRB7pePo7ADK0IoJMLXhoq6IENJSYHWDTcOBm4plrbdbrfVkVtBa8GPUw47o7ol3V6oP14qQGgssSVZ4dasQw9cJ0qhWLlkYBu0hTEkxwpkUgrG58Jd_ocswxfy2G4qKRnBM7qle5w6c70K-2M6iapG_mctK8rnw439QebSwcjZ7q3M5vpPw4mGndy3-sU8G6BbYfHyE7g4hWM0eVVuPquxRtfGompPYNill2PcQ71v6T9ZvgKTm_g |
Cites_doi | 10.1186/s12944-020-01234-6 10.1007/s11845-023-03431-5 10.1097/01.ju.0000169255.64518.fb 10.1155/2015/145647 10.1001/jamaoncol.2021.5143 10.3390/nu15153298 10.1186/s12885-017-3814-3 10.1038/s41598-023-43391-5 10.3322/caac.21660 10.1186/s12890-023-02574-6 10.1055/s-0042-108071 10.3389/fnut.2022.1012181 10.3389/fpubh.2023.1078280 10.4062/biomolther.2023.132 10.1186/1475-2891-9-69 10.1080/03007995.2018.1479683 10.1056/NEJM199902113400607 10.1111/aor.12557 10.3390/ijms231911501 10.1007/s10147-021-01952-6 10.1016/j.amjsurg.2013.03.007 10.4111/icu.20210105 |
ContentType | Journal Article |
Copyright | The Author(s) 2024 2024. The Author(s). COPYRIGHT 2025 BioMed Central Ltd. 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2024 2024 |
Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: COPYRIGHT 2025 BioMed Central Ltd. – notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2024 2024 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12894-024-01687-2 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central Database Suite (ProQuest) ProQuest One ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ: Directory of Open Access Journal (DOAJ) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2490 |
EndPage | 8 |
ExternalDocumentID | oai_doaj_org_article_b2436eb7b56741668c2e3790b95e5b43 PMC11706081 A822584853 39762822 10_1186_s12894_024_01687_2 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFO ACGFS ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7QP 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c559t-79a3d6213cf192179204bdd7698b658ecc40cf02ecdc56fae5115126c1525d553 |
IEDL.DBID | M48 |
ISSN | 1471-2490 |
IngestDate | Wed Aug 27 01:30:17 EDT 2025 Thu Aug 21 18:34:47 EDT 2025 Fri Sep 05 02:57:19 EDT 2025 Fri Jul 25 22:44:24 EDT 2025 Tue Jun 17 21:57:30 EDT 2025 Tue Jun 10 20:53:53 EDT 2025 Wed Feb 19 02:02:12 EST 2025 Tue Jul 01 01:02:49 EDT 2025 Sat Sep 06 07:22:55 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | NHANES Cross-sectional study Albumin-globulin ratio Prostate-specific antigen |
Language | English |
License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c559t-79a3d6213cf192179204bdd7698b658ecc40cf02ecdc56fae5115126c1525d553 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12894-024-01687-2 |
PMID | 39762822 |
PQID | 3152696501 |
PQPubID | 42551 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b2436eb7b56741668c2e3790b95e5b43 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11706081 proquest_miscellaneous_3153866335 proquest_journals_3152696501 gale_infotracmisc_A822584853 gale_infotracacademiconefile_A822584853 pubmed_primary_39762822 crossref_primary_10_1186_s12894_024_01687_2 springer_journals_10_1186_s12894_024_01687_2 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-01-07 |
PublicationDateYYYYMMDD | 2025-01-07 |
PublicationDate_xml | – month: 01 year: 2025 text: 2025-01-07 day: 07 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | BMC urology |
PublicationTitleAbbrev | BMC Urol |
PublicationTitleAlternate | BMC Urol |
PublicationYear | 2025 |
Publisher | BioMed Central BioMed Central Ltd BMC |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
References | E-S Kim (1687_CR23) 2023; 31 BN Azab (1687_CR19) 2013; 206 K Xu (1687_CR8) 2023; 11 C Gabay (1687_CR21) 1999; 340 RD Etzioni (1687_CR4) 2005; 174 H Sung (1687_CR1) 2021; 71 M Zhang (1687_CR3) 2023 Z Xia (1687_CR5) 2022; 9 D Gupta (1687_CR10) 2010; 9 A Aydh (1687_CR12) 2021; 26 S Salciccia (1687_CR13) 2022; 23 J-W Chung (1687_CR11) 2021; 62 SB Asegaonkar (1687_CR22) 2015; 2015 J Li (1687_CR16) 2023; 13 EJ Meyer (1687_CR6) 2016; 48 J Song (1687_CR9) 2020; 19 MS Leapman (1687_CR2) 2022; 8 S Ikeda (1687_CR15) 2017; 17 Y Bozkaya (1687_CR17) 2019; 35 C Pfensig (1687_CR20) 2016; 40 J Chen (1687_CR18) 2023; 23 Q Li (1687_CR14) 2015; 5 H-Y Lin (1687_CR7) 2023; 15 |
References_xml | – volume: 19 start-page: 82 year: 2020 ident: 1687_CR9 publication-title: Lipids Health Dis doi: 10.1186/s12944-020-01234-6 – year: 2023 ident: 1687_CR3 publication-title: Ir J Med Sci doi: 10.1007/s11845-023-03431-5 – volume: 174 start-page: 877 year: 2005 ident: 1687_CR4 publication-title: J Urol doi: 10.1097/01.ju.0000169255.64518.fb – volume: 5 start-page: 2856 year: 2015 ident: 1687_CR14 publication-title: Am J Cancer Res – volume: 2015 start-page: 145647 year: 2015 ident: 1687_CR22 publication-title: Int J Breast Cancer doi: 10.1155/2015/145647 – volume: 8 start-page: 41 year: 2022 ident: 1687_CR2 publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2021.5143 – volume: 15 start-page: 3298 year: 2023 ident: 1687_CR7 publication-title: Nutrients doi: 10.3390/nu15153298 – volume: 17 start-page: 797 year: 2017 ident: 1687_CR15 publication-title: BMC Cancer doi: 10.1186/s12885-017-3814-3 – volume: 13 start-page: 17272 year: 2023 ident: 1687_CR16 publication-title: Sci Rep doi: 10.1038/s41598-023-43391-5 – volume: 71 start-page: 209 year: 2021 ident: 1687_CR1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21660 – volume: 23 start-page: 275 year: 2023 ident: 1687_CR18 publication-title: BMC Pulm Med doi: 10.1186/s12890-023-02574-6 – volume: 48 start-page: 359 year: 2016 ident: 1687_CR6 publication-title: Horm Metab Res doi: 10.1055/s-0042-108071 – volume: 9 start-page: 1012181 year: 2022 ident: 1687_CR5 publication-title: Front Nutr doi: 10.3389/fnut.2022.1012181 – volume: 11 start-page: 1078280 year: 2023 ident: 1687_CR8 publication-title: Front Public Health doi: 10.3389/fpubh.2023.1078280 – volume: 31 start-page: 473 year: 2023 ident: 1687_CR23 publication-title: Biomol Ther (Seoul) doi: 10.4062/biomolther.2023.132 – volume: 9 start-page: 69 year: 2010 ident: 1687_CR10 publication-title: Nutr J doi: 10.1186/1475-2891-9-69 – volume: 35 start-page: 275 year: 2019 ident: 1687_CR17 publication-title: Curr Med Res Opin doi: 10.1080/03007995.2018.1479683 – volume: 340 start-page: 448 year: 1999 ident: 1687_CR21 publication-title: N Engl J Med doi: 10.1056/NEJM199902113400607 – volume: 40 start-page: 397 year: 2016 ident: 1687_CR20 publication-title: Artif Organs doi: 10.1111/aor.12557 – volume: 23 start-page: 11501 year: 2022 ident: 1687_CR13 publication-title: Int J Mol Sci doi: 10.3390/ijms231911501 – volume: 26 start-page: 1729 year: 2021 ident: 1687_CR12 publication-title: Int J Clin Oncol doi: 10.1007/s10147-021-01952-6 – volume: 206 start-page: 764 year: 2013 ident: 1687_CR19 publication-title: Am J Surg doi: 10.1016/j.amjsurg.2013.03.007 – volume: 62 start-page: 545 year: 2021 ident: 1687_CR11 publication-title: Investig Clin Urol doi: 10.4111/icu.20210105 |
SSID | ssj0017856 |
Score | 2.345722 |
Snippet | Purpose
The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen... The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has... Purpose The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen... PurposeThe albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen... Abstract Purpose The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 3 |
SubjectTerms | Adult Age Aged Albumin Albumin-globulin ratio Alcohol Analysis Angina pectoris Antigens Body mass index Cardiovascular disease Chronic illnesses Coronary vessels Creatinine Cross-Sectional Studies Cross-sectional study Dehydrogenases Diabetes Globulins Humans Hypertension Internal Medicine Laboratories Male Medical prognosis Medicine Medicine & Public Health Metastasis Middle Aged NHANES Nitrogen Nutrition Surveys Prostate cancer Prostate-specific antigen Prostate-Specific Antigen - blood Prostatic Neoplasms - blood Prostatic Neoplasms - epidemiology Proteins Regression analysis Serum Albumin - analysis Serum Globulins - analysis Surveys Triglycerides Uric acid Urology Variables Vein & artery diseases |
SummonAdditionalLinks | – databaseName: DOAJ: Directory of Open Access Journal (DOAJ) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtQwFLVQFxUbBOUV2iIjIbGAqI4dP8JuQK1GSJ0NVOrO8ivqbDIjZrpF_EP_kC_hXieZNkWIDdvYUWzfe-Nj-_hcQt4y07ZVgEVOy8EMdcur0qlalypoFhPzSeV0b-cLNb-ov1zKyzupvpAT1ssD9wN34nktVPLaS4XgQZnAk9AN841M0tdZ55M1bFxMDecH2kg1XpEx6mQDf2GUwOXIuFAQVnwyDWW1_j__yXcmpfuEyXunpnkyOntMHg0oks761j8hD1J3QPbPh3Pyp-THjuN2tVzTgYtFMxV52ZUoAoIEdJqtT10X6RovfwDsLPHmJbKH4OkWhTo_UkdzF8pNJm3hZ7MkLcX5L9JVRxfz2eL0K0X-2a-fN3ju_YxcnJ1--zwvh0wLZYAVxbbUjRNR8UqEFvXRdMNZ7WPUqjEeIAqYuWahZTyFGKRqXQKYBkhBBcyeFKUUz8let-rSS0K1TqqKsOxKuKOkHFjORR6EE96EVLUFeT8OvF33gho2L0SMsr2ZLJjJZjNZXpBPaJtdTRTDzg_ARezgIvZfLlKQd2hZiyEL5gtuuHkADUbxKzsDkAQ4DIBLQY4mNSHUwrR49A07hPrGigqTtAPQrQryZleMbyJ9rUur61xHGMB2QhbkRe9Kuy4hIEQub0HMxMkmfZ6WdMurLAReZe0jAx_-MPrjbbv-Pqiv_segHpKHHFMh426UPiJ72-_X6Rjw2da_zqH4G1AANCI priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwEB1BkRAXVD6btiAjIXGAqImd2NleqgW1WiF1L1Bpb1b8EbqXZOlur4j_0H_IL2HG66SkCK5xItuZGfvZfn4D8Darmia3uMhpOJqhaHie1rJQqbQqcz4zXoZ0b-dzObsoPi_KRdxwW0daZT8mhoHadZb2yI9ETrmwEU_kJ6vvKWWNotPVmELjPjwI0mXoz2oxLLgo8bzsL8pU8miNYzEJ4XLiXUgMLj6ajIJm_98j8x9T013a5J2z0zAlne3C44gl2XRr_Cdwz7dP4eF5PC1_Bj8GptvlcsUiI4sFQvKyTUkKhGjoLPgAq1vHVnQFBMFnSvcviUOETzck13nMaha6kK4DdYuqDcK0jGZBx7qWzWfT-ekXRiy0Xz9v6PT7OVycnX79NEtjvoXU4rpik6pJLZzkubANqaSpCc8K45ySk8ogUEFjF5ltMu6ts6Vsao9gDfGCtJRDyZWleAE7bdf6PWBKeZk7XHx52leStVGmdtyKWpjK-rxJ4H3_4_VqK6uhw3KkknprJo1m0sFMmifwkWwzvEmS2OFBd_VNxwjThhdCeqyolIQyZWW5F2qSGWxEaQqRwDuyrKbARfPZOt4_wAaTBJaeIlRCNIbwJYHD0ZsYcHZc3PuGjgG_1rfumcCboZi-JBJb67vr8I6oEOGJMoGXW1caukSwkBi9CVQjJxv1eVzSLi-DHHgeFJAqrPhD74-37fr3T93_fzcO4BGnVMe026QOYWdzde1fIf7amNchyH4D7AUsjg priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwELVQkRAXVL5TCjISEgeIiO147O1tqVqtkLoXqNSbFX9E3Ut21d1eEf-Bf8gvYcabTZsCB66xI9sZj_2ceX7D2LvKtq0IeMhpJZqhbqUoG6hNCcFUMVU-QU73djaH2Xn95UJf9DI5dBfmdvxeWPi0xvWTxGslcSUAHQKX2_taKMiBWTgeIgbGathdivnre6ONJ-vz_7kK39qG7lIk78RJ8_Zzus8e9biRT7eGfszupe4Je3DWR8afsu8Dq-1yseI9-4pn8vGiK0n2gyjnPNubN13kK7rugUCzpLuWxBfCpxuS5jziDc9DKNeZpkXNZhFaTjte5MuOz2fT-clXToyzXz9-UqT7GTs_Pfl2PCv73AplwDPEpjSTRkWQQoWWFNHMRFa1j9HAxHoEJWjYugptJVOIQUPbJARmiA0gUL6kqLV6zva6ZZdeMm5MAhHxoJXoHxI03vgmyqAa5W1Ioi3Yh92Hd6uthIbLRw8Lbmsmh2Zy2UxOFuwz2WaoSfLX-QHOCtd7k_OyVpCwIQ2EKMEGmZSZVB47oX2tCvaeLOvISdF8oenvGmCHSe7KTREWIfJCqFKww1FNdK4wLt7NDdc799opQWnZEdqKgr0diulNIqx1aXmd6yiLaE7pgr3YTqVhSAQBib1bMDuaZKMxj0u6xWWW_hZZ7chiwx938_GmX__-qAf_V_0VeygpzTH9aTKHbG9zdZ1eI_ba-DfZ6X4DtOMlgg priority: 102 providerName: Springer Nature |
Title | Relationship between albumin-globulin ratio and prostate-specific antigen: a cross-sectional study based on NHANES 2003–2010 |
URI | https://link.springer.com/article/10.1186/s12894-024-01687-2 https://www.ncbi.nlm.nih.gov/pubmed/39762822 https://www.proquest.com/docview/3152696501 https://www.proquest.com/docview/3153866335 https://pubmed.ncbi.nlm.nih.gov/PMC11706081 https://doaj.org/article/b2436eb7b56741668c2e3790b95e5b43 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fi9NAEB_OOzjuRfxv9CwrCD5oNNlNdlNBpC09itAip4Xiy5LsbryCpLXtgb6I38Fv6CdxZpv0zHm--BJIdsP-mZmdmd3Z3wA8ibKyjA06OSVHMiQlj8NcJiqURkXWRYWTPt3beCJH0-TtLJ3tQZPuqJ7A9ZWuHeWTmq4-v_j65dsbFPjXXuAz-XKNaywB3HKKp5AoNLgkH6BmkuSMjZOLUwWVpbK5OHPlf0dwSPqZQitbesrD-f-9aP-htS5HVF46VvXa6uQGXK_NTNbb8sVN2HPVLTgc1wfpt-H7LgjubL5kdbAW87HK8yoklBCKUGeePVheWbak2yFol4Z0NZPCi_DrhpA8X7Gc-SGEax_VRc16zFpGCtKyRcUmo95k-J5RgNqvHz_pYPwOTE-GHwajsE7FEBp0OTah6ubCSh4LUxKAmuryKCmsVbKbFWjDIB8kkSkj7ow1qSxzh3YcmhLSUHolm6biLuxXi8rdB6aUk7FFv8zRlpPMC1XklhuRiyIzLi4DeNZMvF5uETe091QyqbcU00gx7SmmeQB9os2uJqFl-w-L1SddC58ueCKkw4ZSSQaozAx3QnWjAjuRFokI4ClRVhOXIflMXl9NwA4TOpbuIT-goYaWTQDHrZooi6Zd3PCGblhZi5iyuKMlHAfweFdMf1J8W-UW576OyND4E2kA97astBtSw5EBZC0ma425XVLNzzxSeOzBkTJs-HnDjxf9-vekPvj_lh7CEacMybRJpY5hf7M6d4_QbNsUHbimZqoDB_3h5N0pvg3koOO3QDpeSvF52v_4G4GNQrM |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB5VWwm4IP4JFDASiANETZzEziIhtIWttrS7QtBKvbmJ7dC9JEt3K8QF8Q68Bw_FkzDj_JQUwa3XOJHtzIzns_3NDMCTIC2KUOMmp-AohrjgoZ-JWPpCy8DYILfClXubzsTkIH53mByuwc82FoZole2a6BZqU2k6I9-MQqqFjXgifL347FPVKLpdbUto1Gqxa79-wS3b8tXOW5TvU863x_tvJn5TVcDXiJ5XvhxmkRE8jHRBucDkkAdxbowUwzRHd4xTigNdBNxqoxNRZBYhCXpFoalSkEmoSgQu-esxRbQOYH1rPHv_obu3kGki2tCcVGwucfWn1LucmB4CzZn33J-rEvC3L_jDGZ4nap67rXVOcPsaXG3QKxvV6nYd1mx5Ay5Nm_v5m_Ct49Ydzxes4YAxR4Gelz4lHyHiO3Nax7LSsAUFnSDc9Snik1hL-HRFCUJfsoy5KfhLRxajbl0qXEZ-17CqZLPJaDb-yIj39uv7D7pvvwUHFyKL2zAoq9LeBSalFaHB7Z6lkyyR5TLPDNdRFuWptmHhwfP2x6tFnchDuQ1QKlQtJoViUk5MinuwRbLp3qQk3O5BdfJJNTatch5HwmJHiSBcK1LNbSSHQY6DSPI48uAZSVbRUoHi01kT8YADpqRbaoTgDPEfAiYPNnpvoonrfnOrG6pZYpbqzCA8eNw105dEmyttdereiVLElFHiwZ1albopERAlDrEHaU_JenPut5TzY5eAPHQ5l1Ls-EWrj2fj-vdPvff_aTyCy5P96Z7a25nt3ocrnAot01mX3IDB6uTUPkD0t8ofNibH4Oiirfw38K5p5w |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6hIlVcEG8CBYyExAGiJnZie7ktpavl0RUSVOrNih9p95JddbdXxH_gH_JLmHEeNAUOXGNHtjMe-3Pmm88ALzJd17nDQ07N0QxFzfO0koVKpVOZD5kNMl73drSQ8-Piw0l5cimLP7Ld-5Bkm9NAKk3Ndn_t69bFtdzf4KpKkracGBQS3QQX4esFbX0UrpUHQxxB6VL2qTJ_fW-0HUXV_j_X5kub01Xi5JXoadyUZrfgZocm2bQ1_224Fpo7sHvUxcvvwreB63a2XLOOk8UiJXnZpCQGQkR0FmcBqxrP1pQEgvAzpQxMYhHh0y0Jdr5hFYtDSDeRvEXNRmlaRvugZ6uGLebTxeEXRjy0n99_UPz7HhzPDr8ezNPuxoXU4clim6pJJbzkuXA16aSpCc8K672SE20RqqC5i8zVGQ_Ou1LWVUC4hohBOrpFyZeluA87zaoJD4EpFWTu8fgV6M-SrKyyledOVMJqF_I6gVf9hzfrVljDxAOJlqY1k0EzmWgmwxN4S7YZapIodnywOj81nY8ZywshAzZUSsKZUjsehJpkFjtR2kIk8JIsa8h10Xyu6jIQsMMkgmWmCJYQjyGASWBvVBNdzo2L-7lhOpffGJHTZe0IePMEng_F9CbR2Jqwuoh1hEaMJ8oEHrRTaRgSAUPi9CagR5NsNOZxSbM8i4LgedRA0tjw634-_u7Xvz_qo_-r_gx2P7-bmU_vFx8fww1O9yDTryi1Bzvb84vwBMHZ1j6N_vcLB0Awtg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Relationship+between+albumin-globulin+ratio+and+prostate-specific+antigen%3A+a+cross-sectional+study+based+on+NHANES+2003%E2%80%932010&rft.jtitle=BMC+urology&rft.au=Gao%2C+Simeng&rft.au=Li%2C+Shaojie&rft.au=Wu%2C+Baofang&rft.au=Wang%2C+Jiayin&rft.date=2025-01-07&rft.pub=BioMed+Central&rft.eissn=1471-2490&rft.volume=25&rft_id=info:doi/10.1186%2Fs12894-024-01687-2&rft_id=info%3Apmid%2F39762822&rft.externalDocID=PMC11706081 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2490&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2490&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2490&client=summon |